JenaValve raises $100M for its transfemoral TAVR system for severe aortic regurgitation

Retrieved on: 2022-09-01 20:56:54

Tags for this article:

Click the tags to see associated articles and topics

JenaValve raises $100M for its transfemoral TAVR system for severe aortic regurgitation. View article details on hiswai:

Excerpt

JenaValve Technology, the California-based medical device company focused on developing new transcatheter aortic valve replacement (TAVR) ...

Article found on: cardiovascularbusiness.com